RxDoctor Payments Data

Hanna Ilia, MD

Family Medicine · Lafayette, TNNPI 1205826526

Payments from drug & device makers

$277in general payments, 2019–2025

Across 15 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$44
  • AstraZeneca$43
  • Lilly USA, LLC$35
  • Corcept Therapeutics$34
  • Organon$24
  • Ardelyx, Inc.$21
  • plus $76 from 5 others

What the payments were for

  • Food & beverage$277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$277 in reported general payments places this provider in the 40th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$195,720
Medicare patients
484
Services billed
3,489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$68,742
XareltoRivaroxaban50$50,127
JardianceEmpagliflozin14$22,047
XifaxanRifaximin11$16,493
JanuviaSitagliptin Phosphate11$12,081
MounjaroTirzepatide11$11,357
Bydureon BciseExenatide Microspheres11$9,728
NamzaricMemantine Hcl/Donepezil Hcl12$7,717
Tresiba Flextouch U-200Insulin Degludec14$7,493
JanumetSitagliptin Phos/Metformin Hcl22$7,386
ShingrixVaricella-Zoster Ge/As01b/Pf33$6,810
FarxigaDapagliflozin Propanediol11$6,703
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$6,586
Memantine Hcl97$5,708
AbrysvoRsv Vacc, Pref A And Pref B/Pf19$5,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$35$11,35711 claims
AbbVieNamzaric$12$7,71712 claims
AstraZenecaFarxiga$43$6,70311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Lafayette

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →